Related Experiment Video
Updated: Apr 23, 2026
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
19.1K
Eletriptan for acute migraine headaches in adults
Sheena Derry1, R Andrew Moore1, Henry J McQuay1
1Pain Research and Nuffield Department of Anaesthetics, University of Oxford, Oxford, UK.
The Cochrane Database of Systematic Reviews
|October 1, 2014
Summary
This review will assess eletriptan's effectiveness and safety for acute migraine headaches in adults. It compares eletriptan against placebo and other treatments to determine optimal migraine management strategies.
Area of Science:
- Neurology
- Pharmacology
- Clinical Trials
Background:
- Migraine is a common neurological disorder.
- Acute treatment options are varied.
- Eletriptan is a triptan medication for migraine.
Purpose of the Study:
- To evaluate the efficacy of eletriptan in treating acute migraine headaches in adults.
- To assess the tolerability and safety profile of eletriptan.
- To compare eletriptan with placebo and other active migraine treatments.
Main Methods:
- Systematic review and meta-analysis protocol.
- Literature search of randomized controlled trials.
- Data extraction on efficacy and tolerability outcomes.
Main Results:
- Eletriptan's efficacy in pain relief and symptom resolution will be quantified.
- Adverse event rates associated with eletriptan will be analyzed.
- Comparative effectiveness of eletriptan versus other interventions will be determined.
Conclusions:
- Evidence on eletriptan's role in acute migraine treatment will be synthesized.
- Clinical implications for migraine management will be discussed.
- Future research directions in migraine pharmacotherapy may be identified.
Related Concept Videos
01:30Electroconvulsive Therapy
2.5K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.5K
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
603
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
603
01:23Antidepressant Drugs: MAOIs and Other Agents
1.2K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.2K
01:17Drugs for Treatment of Diarrhea-Predominant IBS
991
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
991